Psychiatry UK - Private ADHD and Autism Services
Psychiatry-UK is an online psychiatric provider offering private and NHS-funded assessments for ADHD and autism in adults and children, alongside a wider range of psychiatric services covering anxiety, depression, addiction and memory concerns. Founded in 2012, the organisation has grown into one of the largest independent providers of remote psychiatric care in the UK, drawing on a network of more than 280 GMC-registered consultant psychiatrists and prescribing nurses. It says it now supports well over 150,000 patients in total and carries out around 3,000 initial assessments each month, spanning both self-funded work and NHS Right to Choose referrals.
All assessments are delivered by video call rather than in person, conducted via a secure Teams link with a psychiatrist rather than a more junior clinician. For ADHD, patients typically complete preparatory questionnaires — the site points people towards the ASRS (Adult ADHD Self-Report Scale) ahead of a GP referral — followed by a full clinical interview in which the psychiatrist reviews presenting difficulties, developmental and treatment history, and reaches a formal diagnostic decision. For autism, the pathway is similar in structure: patients are encouraged to complete an AQ-10 screening form before referral, with the diagnostic decision then made by an ASD specialist doctor during a video consultation. The site states that its diagnosis rates for both conditions are benchmarked against NHS trust norms and that assessments follow NICE guidance and national assessment frameworks, though it gives limited public detail on which specific structured diagnostic instruments (beyond the screening questionnaires) are used within the assessment itself.
Where a diagnosis leads to a medication recommendation, Psychiatry-UK operates a titration pathway funded by the NHS for Right to Choose patients, with shared care arrangements coordinated back to the patient’s GP for ongoing prescribing. The site is candid that there can be a wait between diagnosis and starting treatment, partly attributed to national medication shortages, and that NHS routes currently run considerably longer than private ones — it quotes roughly five to six months for adult autism and ten to twelve months for adult ADHD via Right to Choose, against around two weeks for a private assessment once pre-assessment forms are complete. For autism specifically, the service acknowledges that post-diagnostic support is currently limited, stating an intention to offer coaching and therapy in future but confirming these are not yet available — a gap worth noting for anyone expecting wraparound support alongside a diagnosis.
Leadership sits with CEO Nell Montgomery, a UKCP-registered psychoanalytic psychotherapist, alongside Chief Medical Officer Dr Jo Farrow and a senior team covering strategy, technology, operations and quality assurance. The organisation is CQC-registered and was rated “”Good”” following its most recent inspection. Its stated values are compassion, ethics, expertise and innovation, framed around a mission to widen access to psychiatric care against a backdrop of NHS capacity pressure — a rationale reflected in its scale of operation and its emphasis on consultant-led, technology-enabled delivery rather than smaller in-person clinics.
Taken together, the public-facing material positions Psychiatry-UK as a high-volume, consultant-delivered telepsychiatry service rather than a boutique or specialist neurodivergence practice — its strength is reach and NHS-funded access via Right to Choose, with assessment content built around established screening tools (ASRS, AQ-10) and structured clinical interview rather than a described neurodiversity-affirming methodology. Anyone considering it should weigh the private route’s shorter two-week turnaround and no-GP-referral requirement against the NHS pathway’s much longer waits, and should be aware that autism assessments currently come without the coaching or therapy follow-on the service has indicated it plans to add.
The Neurodiversity Directory CIC
Company Number 17359613
128 City Road, EC1V 2NX, London
